Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. 2000

M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

In addition to the CCR5 and CXCR4 chemokine receptors, a subset of primary human immunodeficiency virus type 1 (HIV-1) isolates can also use the seven-transmembrane-domain receptor APJ as a coreceptor. A previously identified ligand of APJ, apelin, specifically inhibited the entry of primary T-tropic and dualtropic HIV-1 isolates from different clades into cells expressing CD4 and APJ. Analysis of apelin analogues demonstrated that potent and specific antiviral activity was retained by a 13-residue, arginine-rich peptide. Antiviral potency was influenced by the integrity of methionine 75, which contributes to APJ-binding affinity, and by the retention of apelin residues 63 to 65. These studies demonstrate the ability of a small peptide ligand to block the function of APJ as an HIV-1 coreceptor, identify apelin sequences important for the inhibition, and provide new reagents for the investigation of the significance of APJ to HIV-1 infection and pathogenesis.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011991 Receptors, Virus Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response. Viral Entry Receptor,Viral Entry Receptors,Virus Attachment Factor,Virus Attachment Factors,Virus Attachment Receptor,Virus Attachment Receptors,Virus Entry Receptor,Virus Entry Receptors,Virus Receptor,Virus Receptors,Attachment Factor, Virus,Attachment Factors, Virus,Attachment Receptor, Virus,Attachment Receptors, Virus,Entry Receptor, Viral,Entry Receptor, Virus,Entry Receptors, Viral,Entry Receptors, Virus,Receptor, Viral Entry,Receptor, Virus,Receptor, Virus Attachment,Receptor, Virus Entry,Receptors, Viral Entry,Receptors, Virus Attachment,Receptors, Virus Entry
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073861 Apelin A 77 amino acid secreted endogenous ligand for the angiotensin II receptor-like 1 protein (APELIN RECEPTOR) that is proteolytically cleaved into four smaller peptides: Apelin-36, Apelin-31, Apelin-28, and Apelin-13. It inhibits entry of HIV into cells that express both APJ and CD4 ANTIGEN and is highly expressed in breast milk, where it may modulate the neonatal immune response.
D000075244 Apelin Receptors G-protein coupled receptors for APELIN that function in a broad range of physiologic processes including blood pressure regulation and heart contractility. They also have an essential role in early embryo development for GASTRULATION and heart morphogenesis, and can also function as a CD4 co-receptor for HIV-1. APLNR,Angiotensin Receptor-Like 1 Protein,Apelin Receptor,Receptors, Apelin,Angiotensin Receptor Like 1 Protein,Receptor, Apelin
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
July 1998, Journal of virology,
M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
October 1999, Biochimica et biophysica acta,
M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
September 2002, Circulation research,
M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
October 1998, Journal of virology,
M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
September 1996, Journal of virology,
M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
January 2000, Journal of neurochemistry,
M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
January 2006, Ernst Schering Foundation symposium proceedings,
M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
June 2003, European journal of pharmacology,
M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
May 2000, FEBS letters,
M Cayabyab, and S Hinuma, and M Farzan, and H Choe, and S Fukusumi, and C Kitada, and N Nishizawa, and M Hosoya, and O Nishimura, and T Messele, and G Pollakis, and J Goudsmit, and M Fujino, and J Sodroski
June 2011, Hypertension research : official journal of the Japanese Society of Hypertension,
Copied contents to your clipboard!